LYNNETTE KENNISON: Open Payments
NPI 1053510149 · JACKSONVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,541 in 71 payments from 17 companies in 2025. Trend: 2023 $2,098 · 2024 $1,368 · 2025 $1,541
Food & beverage: $1,541
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 17 | $399 |
| Lundbeck LLC | 5 | $143 |
| Teva Pharmaceuticals USA, Inc. | 7 | $128 |
| Neurocrine BioSciences, Inc. | 6 | $114 |
| ABBVIE INC. | 6 | $106 |
| Janssen Pharmaceuticals, Inc | 5 | $102 |
| Alkermes, Inc. | 4 | $102 |
| Axsome Therapeutics, Inc. | 4 | $85 |
| E.R. Squibb & Sons, L.L.C. | 3 | $65 |
| Otsuka America Pharmaceutical, Inc. | 3 | $60 |
Products named: CAPLYTA, REXULTI, AUSTEDO XR, INGREZZA, VRAYLAR, ARISTADA, Auvelity, COBENFY.
Industry payments across FL — which companies pay providers there.
